Updates in CLL: A Closer Look at Adverse Events

Carrie Lenneman, MD, MSCI, and Farrukh Awan, MD, discuss adverse events associated with treating chronic lymphocytic leukemia, particularly when utilizing BTK inhibitors.

EP. 1: A Review of Treatment Options in CLL

October 7th 2021

Carrie Lenneman, MD, MSCI, and Farrukh Awan, MD, give an overview of chronic lymphocytic leukemia, the standard of care for treatment, and the current and emerging BTK inhibitors used to treat CLL.

EP. 2: Key Safety Considerations

October 7th 2021

Two experts discuss key safety considerations when treating patients with chronic lymphocytic leukemia.

EP. 3: Baseline Testing Prior to Initiation of BTKi Treatment in CLL

October 7th 2021

Drs Lenneman and Awan discuss baseline testing before choosing a treatment strategy for battling chronic lymphocytic leukemia.

EP. 4: Balancing the Risk and Benefit of Anticoagulation in Patients on BTKi

October 7th 2021

Carrie Lenneman, MD, MSCI, and Farrukh Awan, MD, review the risk versus benefit of anticoagulation strategies in patients on BTKi.

EP. 5: Strategies for Managing Atrial Fibrillation in Patients on BTKi

October 15th 2021

Two experts discuss strategies for managing atrial fibrillation in patients with CLL on BTKi therapy.

EP. 6: A Real-World Case of a Patient with CLL and a Cardiac History

October 15th 2021

Farrukh Awan shares a case of a patient with a cardiac history recently diagnosed with CLL requiring treatment.

EP. 7: Strategies for Managing Hypertension in Patients with CLL

October 21st 2021

Carrie Lenneman, MD, MSCI, and Farrukh Awan, MD, review strategies for managing hypertension in patients with CLL.

EP. 8: Experts Answer Audience Questions Related to Adverse Events of BTKi

October 21st 2021

Carrie Lenneman, MD, MSCI, and Farrukh Awan, MD, close out the program answering audience questions regarding potential adverse events surrounding the utilization of BTK inhibitors in the management of chronic lymphocytic leukemia.